Global LED Panel Mount Indicators Growth Potential Report 2019

The global LED Panel Mount Indicators market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on LED Panel Mount Indicators volume and value at global level, regional level and company level. From a global perspective, this report represents overall LED Panel Mount Indicators market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Mouser

Dialight

Lumex

Bulgin

APEM

Kingbright

Honeywell

Visual Communications

Bivar

Everlight Electronics

IDEC

MARL

Wamco

Micropac Industries

Multicomp

Schneider Electric

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Monochromatic

Multicolor

Segment by Application

Electronics

Automotive

Medical

Aerospace & Defense

Power

The global intravenous access devices market is projected to reach $68.53 Billion by the end of 2025

The rate at which the incidence of chronic ailments is rising has turned governments topsy-turvy, leaving no option but to increase their research funding. The scenario has been a key force in driving the innovation of medical devices. Administering precise units of drugs or treatments accurately is the most critical aspect of delivering patient care. Hence the demand for devices enabling chemotherapy for treatment, precise blood extraction for diagnosis, and administration of various drugs such as analgesics has picked pace. The prevalent situation is considered to be the most conducive for growth of the global intravenous access devices market.   According to Crystal Market Reports, the global intravenous access devices market is poised to report a CAGR of 7.8% between 2015 and 2025. At this pace, the market’s valuation is projected to reach $68.53 Billion by the end of 2025. 

Global yacht charter market rise from a valuation of $8.71 billion in 2017 to $16.06 billion by 2026

Yacht chartering - the act of renting yachts for corporate or recreational purposes - has emerged as a highly lucrative business in the past few years. Owing to the fact that the maintenance of yachts incurs vast expenses and yachts are used only occasionally by their owners, the provision of yacht chartering gives yacht owners a convenient and sure-shot way of recovering the equally vast maintenance costs of yachts. In the past few years, factors such as the rising population of affluent people across the globe, the rising popularity of yacht vacations amongst young people, and the ease of booking yachts owing to the vast development of the online booking platforms have collectively propelled the global yacht charter market. Global yacht charter market will register a 7.2% CAGR over the period between 2018 and 2026. If the estimate holds true, the market could rise from a valuation of $8.71 billion in 2017 to $16.06 billion by 2026.

Oral thin films market to rise at a 13.08% CAGR during the forecast tenure 2018-2026

The global oral thin films market is foreseen to gain momentum with rising adoption in the pharmaceuticals industry. Oral thin films put a number of advantages on the table. For instance, they offer quick absorption of drugs and high bioavailability. Furthermore, they offer ease of handling and transportation, bypassing of hepatic first pass effect, and fast onset of action. They are also used to help reduce opioid abuse, especially in the U.S. This could be evident with Redwood Scientific Technologies’ (RSCI) decision to explore the possibility of using oral thin film strips to deliver prescription opioids. Announced in April 2018, this decision is backed by another initiative of using its own barcodes and individual blockchain proprietary techniques to monitor, track, and ensure safety of all levels of opioid-based products.